Congress Abstracts 2005

For your convenience, all Podium and Poster Abstracts have been indexed according to number, subject and first author.

The abstracts appear exactly as they were submitted and have not undergone editing or the Oncology Nursing Forum Editorial Board’s review process. We have made every effort to be accurate. If any errors or omissions have been made, please accept our apologies.

Abstracts that are not being presented do not appear.

1
USE OF TELEVISED ANNOUNCEMENTS TO IMPROVE SCREENING AND RECRUITMENT OF AFRICAN-AMERICAN MALES TO A CANCER PREVENTION STUDY.

2
ONCOLOGY NURSING SOCIETY DEVELOPS LEADERS TO GO ABOVE AND BEYOND COMMUNITY.

3
IMPROVING THE QUALITY OF NURSING RESEARCH: A RESEARCH APPROVAL PROCESS.

4
THE RESEARCH NURSES ROLE IN MAXIMIZING CLINICAL TRIAL ACCRUALS IN A COMMUNITY-BASED PRACTICE: A BLUEPRINT FOR SUCCESS.

5
IMPROVING RESEARCH DATA INTEGRITY: APPLYING NOVEL TOOLS IN A LONGITUDINAL BREAST CANCER CLINICAL TRIAL.

6
VALIDATING SELF-REGULATION THEORY IN LUNG CANCER.

7
AN INTERVENTION TO INFLUENCE KNOWLEDGE, HEALTH BELIEFS, AND INTENTION TO SCREEN IN PERSONS AT INCREASED RISK FOR COLON CANCER.

8
A COLLABORATIVE APPROACH TO CARE OF THE PATIENT AFTER TRAM FLAP SURGERY: IN THE HOSPITAL AND BEYOND.

9
OUTCOMES OF A NURSE PRACTITIONER MANAGED PRE-ADMISSION TESTING CENTER AT A MAJOR METROPOLITAN CANCER CENTER.

10
UNDERSTANDING KYPHOPLASTY AS TREATMENT FOR VERTEBRAL COMPRESSION FRACTURES.

11
SUCCESSFUL RADIOIMMUNOTHERAPY WITH ZEVALIN IN A 90-YEAR-OLD PATIENT WITH RELAPSED NON-HODGKIN LYMPHOMA.

12
PREDICTIVE VARIABLES IN MEN’S TREATMENT CHOICES FOR LOCALIZED PROSTATE CANCER.

13
CHEMOTHERAPY HANDLING AND EFFECTS AMONG NURSES AND THEIR OFFSPRING.

14
INDIGENOUS HELPERS FOR SMOKING CESSATION.

15
A META-ANALYSIS OF THE SENSITIVITY OF VARIOUS NEUROPSYCHOLOGICAL TESTS USED TO DETECT CHEMOTHERAPY-INDUCED IMPAIRMENTS IN COGNITIVE FUNCTION.

16
ACHIEVING EXCELLENCE IN BLOOD AND MARROW TRANSPLANT PATIENT CARE: DEVELOPMENT OF A REGIONAL TRANSPLANT EDUCATION PROGRAM AS A CHAPTER SPECIAL PROJECT.

17
DECREASING THE INCIDENCE OF RSV IN AN OUTPATIENT BMT SETTING.

18
THE DEVELOPMENT OF AN ALGORITHM MANAGING ACUTE DELIRIUM IN PATIENTS UNDERGOING ALLOGENIC STEM CELL TRANSPLANT (SCT).

19
ORAL ASSESSMENT: DIFFERENTIATING BETWEEN MUCOSITIS AND STOMATITIS.

20
CHANGING CHILDHOOD CANCER SURVIVORS HEALTH BEHAVIORS TO MODIFY RISKS OF LATE EFFECTS.

21
A MODEL FOR INTEGRATING ONCOLOGY AND GERONTOLOGY IN AN ADVANCED PRACTICE NURSING PROGRAM.

22
SYMPTOM CORRELATES IN THE GERIATRIC ONCOLOGY POPULATION: AN EVIDENCE-BASED REVIEW.

23
ADOLESCENTS THROUGH THE LOOKING GLASS: THE LOOK GOOD FEEL BETTER PROGRAM FOR TEENS.

24
USING THE LEVINE CONSERVATION MODEL TO GUIDE AN INTERVENTION TRIAL OF EXERCISE TO MITIGATE CANCER TREATMENT-RELATED FATIGUE.

25
THE MEANING OF PROSTATE CANCER TREATMENT-RELATED INCONTINENCE AND IMPOTENCE AMONG LOW-INCOME AFRICAN AMERICAN MEN.

26
EXPLORING THE RELATIONSHIPS BETWEEN CANCER PAIN, ATTITUDINAL BARRIERS, AND PTSD: A DESCRIPTIVE STUDY.

27
ONCOLOGY CLINICAL NURSE SPECIALISTS IMPLEMENT A CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING EVIDENCE-BASED PROJECT.

28
UNITING ONCOLOGY NURSES TO DECREASE VARIABILITY IN AMIFOSTINE ADMINISTRATION.

29
HYPODERMOCLYSIS AND INTERMITTENT SUBCUTANEOUS MEDICATION ADMINISTRATION FOR HYDRATION, ANALGESIA AND PALLIATIVE SEDATION IN THE ACUTE PALLIATIVE CARE SETTING.

30
SKIN AND WOUND ACTION TEAM (SWAT): TACTICS TO COMBAT SKIN AND WOUND ISSUES.

31
COLLABORATING TO IMPROVE CANCER-RELATED FATIGUE: A MULTIDISCIPLINARY THORACIC ONCOLOGY TEAM IMPLEMENTS THE NCCN GUIDELINES FOR SCREENING CANCER-RELATED FATIGUE IN THE AMBULATORY SETTING.

32
RISK FACTOR SCREENING TOOL FOR LUNG CANCER (RFST-LC) REVISED: PILOT DATA.

33
RECRUITMENT CHALLENGES FOR LUNG CANCER NURSING RESEARCH.

34
ANALYZING AMBULATORY ONCOLOGY NURSES TELEPHONE MEDIATED DECISION SUPPORT: FACILITATING SYMPTOM MANAGEMENT SELF-CARE.

35
A TARGETED BREAST CANCER EDUCATION INTERVENTION (BCEI) FOR BREAST CANCER SURVIVORS: AN INTERIM ANALYSIS.

36
INTERNET RESOURCE FOR PARENTS OF CHILDREN WITH CANCER.

37
INFORMATION SEEKING BEHAVIOR AMONG INDIVIDUALS RECEIVING TREATMENT FOR CANCER.

38
HAND-FOOT SYNDROME: WHATS NEW IN 2005? AN UPDATE ON CURRENT MANAGEMENT STRATEGIES.

39
CHEMOTHERAPY SIDE EFFECTS: DEVELOPING A RISK ASSESSMENT TOOL FOR USE WITH PATIENTS PRIOR TO THEIR FIRST CYCLE OF CHEMOTHERAPY.

40
SYMPTOM ASSESSMENT: A LOOK AT THE CONGRUENCY OF THE PATIENT NURSE PERSPECTIVES.

41
A SOLUTION FOR PAINFUL SURFACE WOUNDS: A CASE STUDY.

42
NURSING MANAGEMENT OF PATIENTS UNDERGOING HEPATIC EMBOLIZATION FOR HEPATOCELLULAR CARCINOMA.

43
COMBINED MODALITY THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL CANCER: THE NURSES ROLE IN MANAGING SIDE EFFECTS.

44
AN INNOVATIVE AND CREATIVE SOLUTION FOR GASTRIC OUTLET OBSTRUCTION—EXTRACORPOREAL GASTRIC ASSIST DEVICE (EGAD): IMPLICATIONS FOR NURSING.

45
MANAGEMENT OF PATIENTS EXPERIENCING MALABSORPTION STATUS POST PANCREATIC RESECTION.

46
TRENDS IN THE USE OF PALLIATIVE CHEMOTHERAPY IN HOSPICE.

47
END OF LIFE CARE.

48
APPROACHING DEATH: A PHENOMENOLOGICAL STUDY.

49
SYMPTOMS AT END-OF-LIFE AMONG INDIVIDUALS WITH CANCER NOT DESIGNATED AS TERMINAL.

50
NURSE-DEVELOPED SURVEILLANCE PROTOCOL TO DECREASE VRE INFECTIONS IN IMMUNOCOMPROMISED PATIENTS.

51
GETTING TO THE HEART OF CARDIOPULMONARY EMERGENCIES IN ONCOLOGY PATIENTS.

52
ABSTRACT WITHDRAWN.

53
FROM HEART FAILURE TO HEART SUCCESS: IMPROVING OUTCOMES IN CANCER PATIENTS WITH HEART FAILURE THROUGH COLLABORATIVE PRACTICE.

54
DEVELOPING AN EVIDENCED BASED TELEPHONE FOLLOW UP PROGRAM IN RADIATION ONCOLOGY.

55
STRATEGIES NON-PEDIATRIC NURSES CAN USE FOR PREPARING THE PEDIATRIC PATIENT FOR CANCER TREATMENTS.

56
FROM FEAR TO FACT: STRATEGIES FOR ENHANCING RADIATION SAFETY KNOWLEDGE AND ATTITUDES AMONG NURSES.

57
IMAGE GUIDED INTENSITY MODULATED RADIATION THERAPY (IMRT) AND STEREOTACTIC IMMOBILIZATION BODY FRAME: A NOVEL APPROACH TO TREATMENT OF PARASPINAL TUMORS.

58
CHAIRSIDE CHECKLIST: AN INNOVATION IN SAFE CHEMOTHERAPY ADMINISTRATION.

59
IMPLEMENTATION OF AN INNOVATIVE NEW PROTOCOL TO DESENSITIZE PATIENTS SENSITIVE TO TAXOL/CARBOPLATIN.

60
THE PATIENT/FAMILY LEARNING CENTER: AN APPROACH TO ACHIEVING SELF EFFICACY.

61
CHEMOTHERAPY/BIOTHERAPY SAFETY ASSURANCE PROJECT: NETWORK SAFETY THROUGH INTERDISCIPLINARY COLLABORATION.

62
USE OF THERAPEUTIC TOUCH TO DECREASE PATIENT ANXIETY AND TO IMPROVE PATIENT RESPONSE.

63
IMPLEMENTING SYSTEMATIC SCREENING OF DISTRESS INTO ONCOLOGY NURSING PRACTICE.

64
A REPORT CARD ON ONCOLOGY NURSES: SURVEY OF PATIENTS WITH METASTATIC BREAST CANCER.

65
PATIENTS EXPERIENCES OF RECEIVING RADIATION TREATMENT FOR HEAD & NECK CANCER: A QUALITATIVE STUDY.

66
DEVISING A CONSULTATIVE SERVICE FOR NURSES WISHING TO SUBMIT AND PRESENT ABSTRACTS AT PROFESSIONAL MEETINGS.

67
ABSTRACT PREPARATION PROGRAM.

68
THE DEVELOPMENT OF A PROFESSIONAL EDUCATION COMMITTEE AT A COMMUNITY-BASED CANCER CENTER.

69
ONCOLOGY NURSING RETREAT: CREATING A COMMUNITY FOR CANCER NURSING PRACTICE.

70
INTERDISCIPLINARY COLLABORATION: MAKING ALLERGY HISTORIES PRESENT.

71
LINKING SUCCESS AND FAILURE: IMPACTS ON ONCOLOGY NURSES ACCEPTANCE AND USE OF A NEW ELECTRONIC MEDICAL RECORD (EMR).

72
DEVELOPMENT OF A COMPUTERIZED PATIENT EDUCATION SYSTEM IN THE CLINICAL SETTING.

73
EMPOWERMENT: THE RESPONSE OF AN EMPLOYEE OPINION SURVEY.

74
ONCOLOGY NURSES AS SERVICE LINE ADMINISTRATORS: A UNIQUE BLEND OF ROLES.

75
IMPLEMENTING A PALLIATIVE CARE CONSULT SERVICE.

76
SUCCESSFUL STRATEGIES FOR JOB-SHARING THE CASE MANAGER ROLE.

77
MAXIMIZING THROUGHPUT FOR ONCOLOGY OUTPATIENTS.

78
SU11248: A NOVEL DRUG GIVING RENAL CANCER PATIENTS NEW HOPE.

79
EXPANDING APPLICATIONS OF COLONY STIMULATING FACTORS: MUCOSITIS, DIARRHEA, WOUND HEALING, AND CROHN DISEASE.

80
CLINICAL VACCINE TRIALS: LESSONS FOR ONCOLOGY NURSES.

81
THE AMBULATORY NURSE: A VITAL ASSET TO PATIENTS TAKING INTERFERON.

82
ADDRESSING ONCOLOGICAL PAIN THROUGH A MULTIDISCIPLINARY (MDC) APPROACH.

83
PERCEIVED NEED FOR SYMPTOM MANAGEMENT IN THE OUTPATIENT UNIT.

84
PREDICTORS OF COMPLEMENTARY AND ALTERNATIVE THERAPY USE BY CANCER PATIENTS.

85
UTILIZING OPEN FORUM SESSIONS TO INCREASE AWARENESS AND SELF-CARE REGARDING THE PREVENTION AND TREATMENT OF LYMPHEDEMA.

86
A DEADLY TRIO: CANCER, AGGRESSIVE CHEMOTHERAPY, AND TYPHLITIS. INCREASING THE ONCOLOGY NURSES KNOWLEDGE OF THIS UNKNOWN COMPLICATION.

87
THE IMPLEMENTATION OF TELEMETRY MONITORING ON A THORACIC UNIT.

88
HANDS-ON EDUCATIONAL APPROACH TO IMPROVE COGNITION IN CANCER PATIENTS.

89
MANAGING DIABETES IN THE ONCOLOGY PATIENT: PATIENT EDUCATION STRATEGIES.

90
TREATMENT OF ANEMIA WITH DARBEPOETIN ALFA (ARANESP) IN THE RADIATION ONCOLOGY SETTING.

91
LOWER EXTREMITY LYMPHEDEMA IN THE GYNECOLOGIC PATIENT.

92
SUCCESSFUL DELAYS OF MUCOSITIS IN HEAD AND NECK CANCER PATIENTS RECEIVING RADIATION THERAPY: TOOLS OF COMMUNITY RADIATION NURSES.

93
MALIGNANT PLEURAL EFFUSIONS: ADVANTAGES OF PALLIATIVE OUTPATIENT MANAGEMENT WITH THE PLEURX CATHETER.

94
SELF-PERCEPTION OF PATIENTS DEVELOPING CUTANEOUS TOXICITY DURING TREATMENT WITH CETUXIMAB (ERBITUX): BUILDING NURSING KNOWLEDGE.

95
SKIN TOXICITIES AND GEFITINIB (IRESSA): A NURSING CARE PLAN.

96
COMPLETE URINARY OBSTRUCTION (CUO) AND RADIATION RECALL DERMATITIS (RRD) ASSOCIATED WITH TAXOTERE: CASE REPORT AND LITERATURE REVIEW.

97
MANAGING SKIN RELATED INFECTIONS IN CUTANEOUS T CELL LYMPHOMA PATIENTS WITH IONIC SILVER IMPREGNATED DRESSINGS.

98
THE USE OF URODYNAMICS IN THE EVALUATION OF THE CANCER PATIENT WITH LOWER URINARY TRACT DYSFUNCTION.

99
CENTRAL LINE CARE: CHLORHEXADINE VERSUS BETADINE.

100
CATHFLO ACTIVASE PROTOCOLS FOR MANAGING CENTRAL VENOUS ACCESS DEVICE OCCLUSIONS.

101
AN ALTERNATIVE TO IV FLUIDS—HYPODERMOCLYSIS.

102
CENTRAL VENOUS CATHETER INSERTION MADE EASY: PRE-PRINTED ORDER SETS AND INFORMED CONSENT VIDEO.

103
IV ACCESS PROGRAM FOR SUPPORTIVE CARE IN CANCER: PERIPHERALLY INSERTED CENTRAL CATHETER.

104
EMR COMPETENCY: A KEY TO PATIENT SAFETY.

105
UNIVERSAL PLANS OF CARE FOR THE ONCOLOGY POPULATION.

106
COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE): AN INTERDISCIPLINARY APPROACH TO IMPROVE ONCOLOGY PATIENT CARE.

107
DEVELOPMENT OF A RESOURCE GUIDE FOR FAMILY CAREGIVERS TO ENHANCE THE CAREGIVING EXPERIENCE.

108
FAMILY CAREGIVER PATHWAY: THE DRIVING FORCE FOR MAINTENANCE OF LIFE BALANCE OF THE CAREGIVER THROUGHOUT THE CANCER EXPERIENCE.

109
FAMILY PRESENCE: OPENING THE DOOR IN ONCOLOGY.

110
ENHANCING STANDARDS OF CARE: AN ONCOLOGY CLINICAL PRACTICE COUNCIL.

111
AN INNOVATIVE LEADERSHIP APPROACH DURING A WORLD WIDE NURSING SHORTAGE.

112
RESTRUCTURING A ROLE: USING STAFF INPUT TO DEFINE CLINICAL LEADER RESPONSIBILITIES.

113
A CARE GUIDE FOR THE NEWLY DIAGNOSED CANCER PATIENT.

114
EDUCATING PATIENTS ON THE NEW AND IMPROVED CHEST TUBE DRAIN TO MANAGE PERSISTENT AIR LEAKS AT HOME.

115
THE BRAIN & SPINE CENTER HANDBOOK FOR PATIENTS WITH NEUROFIBROMATOSIS.

116
EXTENDING AND EVALUATING TELEPHONE EDUCATION WORKSHOPS IN AN UNDERSERVED POPULATION: HELPING HISPANIC PATIENTS NAVIGATE NEW CANCER KNOWLEDGE.

117
UTILIZING A MULTIDISCIPLINARY PSYCHOSOCIAL APPROACH TO SUPPORT FOR THORACIC ONCOLOGY PATIENTS.

118
DEVELOPMENT OF MULTILINGUAL LOW LITERACY TEACHING MATERIALS IN A DIVERSE COMMUNITY BASED HEALTH CARE SYSTEM.

119
STRATEGIES TO PROMOTE SPIRITUAL WELL-BEING IN PATIENTS WITH CANCER.

120
RICHER DEFINITIONS OF QUALITY OF LIFE (QOL) USING CLASSIC LITERATURE AND FILM TO EXPAND PERCEPTIONS.

121
CONCERNS OF SURGICAL UROLOGY PATIENTS: A COMPARISON OF PATIENTS AND NURSES PERSPECTIVES OF PSYCHOSOCIAL AND SEXUAL ISSUES.

122
CARE OF THYROID CANCER PATIENTS RECEIVING A SYSTEMIC DOSE OF IODINE-131.

123
SETTING THE PACE IN RADIATION ONCOLOGY.

124
CREATION OF A PEDIATRIC PROGRAM IN AN ADULT RADIATION CENTER.

125
BUILDING AN ALLIANCE: COLLABORATING THE CARE OF PEDIATRIC RADIATION PATIENTS BETWEEN A CHILDRENS HOSPITAL AND AN URBAN ADULT TEACHING HOSPITAL.

126
LEARNING ONCOLOGY NURSING FROM THE EXPERTS: USING ONS MEMBERS TO TEACH BSN STUDENTS.

127
INTRODUCING STUDENT NURSES AND TEENS TO THE SPECIALTY OF ONCOLOGY NURSING: A MENTORSHIP OPPORTUNITY.

128
ASSESSMENT OF MORAL DISTRESS EXPERIENCE OF NURSING STUDENTS AND ONCOLOGY STAFF NURSES IN CARING FOR PATIENTS AT END OF LIFE.

129
GROWING OUR OWN ONCOLOGY NURSES.

130
FROM CONGRESS TO HOME: IMPLEMENTING IDEAS LEARNED AT ONS CONGRESS AT YOUR OWN INSTITUTION.

131
LESSONS FROM THE GROUP: THE BENEFITS OF PSYCHOEDUCATIONAL SUPPORT GROUP LEADERSHIP FOR ONCOLOGY NURSES.

132
DEVELOPMENT OF A REVIEW PROGRAM DESIGNED TO ASSIST NURSES IN PREPARING FOR ONCOLOGY CERTIFICATION EXAMINATION.

133
USING A WORKING GROUP TO ENCOURAGE AND FACILITATE SCHOLARSHIP AMONG NURSE CLINICIANS AND MANAGERS.

134
FOSTERING PROFESSIONAL DEVELOPMENT IN AN AMBULATORY SETTING.

135
TAKETEN: AN ELEARNING BREAK FOR ONCOLOGY NURSES.

136
DEVELOPING A PERSONAL DIGITAL ASSISTANT (PDA) REFERENCE TOOL FOR ONCOLOGY NURSES: PROCESS, OUTCOME AND DISSEMINATION.

137
LAYING THE GROUNDWORK: THE IMPORTANCE OF STAFF AND PATIENT EDUCATION IN IMPLEMENTING A NEW TREATMENT MODALITY.

138
CHEMOTHERAPY-RELATED COGNITIVE DYSFUNCTION: AN EDUCATIONAL NEEDS AREA IMPROVED BY A SINGLE INTERVENTION.

139
CROSS CULTURAL EDUCATION: IMPLICATIONS FOR ONCOLOGY NURSING PRACTICE.

140
A NURSING RETREAT: A TIME TO TEACH, STRENGTHEN, AND RENEW THE RADIATION ONCOLOGY NURSE.

141
ASSESSMENT OF A PATIENT IN AN ACUTE PALLIATIVE CARE UNIT.

142
THE NURSE AS DETECTIVE IN ASSESSING FOR PSYCHIATRIC ILLNESS AND DETERMINING THE NEED FOR REFERRAL OR CONSULTATION IN THE ONCOLOGY SETTING.

143
AN EDUCATIONAL PROGRAM TO INCREASE STEM CELL TRANSPLANT NURSES KNOWLEDGE OF INFECTIOUS ISSUES IN THE COMPROMISED HOST.

144
YOGA AT YOUR DESK: SELF CARE AND STRESS MANAGEMENT FOR THE BUSY CLINICIAN.

145
CRITICAL THINKING THROUGH CHEMOTHERAPY ADMINISTRATION.

146
CLORETAZINE (VNP40101M): A NOVEL THERAPY FOR ACUTE MYELOID LEUKEMIA AND MALIGNANT GLIOMAS.

147
DEVELOPMENT OF AN INTRANET WEBSITE TO DISSEMINATE EVIDENCE-BASED PRACTICE INFORMATION.

148
BRIDGING THE GAP: RURAL ONCOLOGY NURSING EDUCATION.

149
OUTPATIENT EXPERIENCE FOR INPATIENT NURSES ON A LEUKEMIA UNIT: A SIMPLE STRATEGY TO PROVIDE A COMPREHENSIVE INTERPRETATION OF THE HEALTHCARE CONTINUUM.

150
THE MISSING LINK IN NURSING ORIENTATION: INTRODUCING CLINICAL RESEARCH TRIALS.

151

THE IMPORTANCE OF A GN ORIENTATION PROGRAM IN CANCER CARE: AN INTERNATIONAL PERSPECTIVE.

152
DEVELOPMENT AND IMPLEMENTATION OF ONCOLOGY FOCUSED NURSE INTERNSHIP.

153
PLANTS USED IN CONVENTIONAL CANCER THERAPY.

154
CANCER SYMPTOM MANAGEMENT: A DIFFERENT WAY OF LEARNING.

155
RECOGNIZING THE NEED TO DEVELOP A NUTRITION SUPPORT PROTOCOL FOR HEAD AND NECK CANCER PATIENTS.

156
INNOVATIVE PRACTICE: ESTABLISHING A PALLIATIVE CARE CLINIC FOR OLDER ADULTS IN A COMPREHENSIVE CANCER CENTER.

157
TOOLS UTILIZATION IN THE COMPREHENSIVE ASSESSMENT OF CANCER-RELATED FATIGUE.

158
TAKING THE PAIN OUT OF CHEST TUBE REMOVAL.

159
PAIN (THE FIFTH VITAL SIGN): ADVANCED CANCER CARE AT END-OF-LIFE IMPLICATIONS FOR NURSING.

160
PARAVERTEBRAL BLOCK: PROMOTING SATISFACTION OF BREAST CANCER PATIENTS IN THE AMBULATORY SURGERY SETTING.

161
THE ROLE OF NURSES IN MANAGING TELEPHONE CALLS FOR SYMPTOMS AND CHEMOTHERAPY TOXICITY.

162
NEW PAIN CONSCIOUSNESS RATING: DECREASING OPIOID RELATED ADRS.

163
THE SIGNIFICANCE OF HAIR CHANGES ASSOCIATED WITH CETUXIMAB.

164
CONCURRENT CHEMORADIOTHERAPY FOR LUNG CANCER: THE MULTI-FACETED ROLE OF THE AMBULATORY CARE NURSE IN PATIENT CARE.

165
INTEGRATING ONCOLOGY AND NEUROLOGY NURSING TO CARE FOR MYASTHENIA GRAVIS PATIENTS TREATED WITH HIGH DOSE CYCLOPHOSPHAMIDE.

166
VIDEO ASSISTED THORACIC SURGERY (VATS): AN INSIDE VIEW OF THE NURSING MANAGEMENT.

167
THE NURSES ROLE IN SYMPTOM MANAGEMENT AND FOLLOW UP OF PATIENTS WITH HEAD AND NECK CANCER RECEIVING MULITI-MODALITY THERAPY.

168
DENDRITIC CELLS: EMERGING ROLES IN TUMOR IMMUNOTHERAPY.

169
NEW THERAPIES FOR TREATMENT OF MYLEODYSPLASTIC SYNDROME.

170
HIGH DOSE INTERLEUKIN—THERAPY DELIVERED COMPETENTLY AND CONFIDENTLY USING THE CAT TOOLS (COORDINATED, ACCURATE AND TIMELY).

171
ELIMINATE MEDICATION ERRORS: A QUALITY IMPROVEMENT INITIATIVE.

172
NY-ESO-1. A NOVEL VACCINE TRIAL FOR UROTHELIAL CANCER.

173
DEVELOPMENT OF A STRATEGY TO SUCCESSFULLY CONVERT AN AMBULATORY INFUSION CENTER FROM PROCRIT (EPOETIN ALFA) TO ARANESP (DARBEPOETIN ALFA).

174
INTERDISCIPLINARY MANAGEMENT OF THE PATIENT RECEIVING HIGH DOSE INTERLEUKIN 2: DEVELOPMENT OF A CLINICAL PATHWAY.

175
NON-ALLERGIC ACUTE INFUSION REACTIONS: MECHANISM OF ACTION, PREVENTION, AND MANAGEMENT GUIDELINES.

176
NURSING CHALLENGES FOR TREATING RELAPSED MULTIPLE MYELOMA WITH BORTEZOMIB (VELCADE) COMPARED WITH HIGH-DOSE DEXAMETHASONE.

177
IMPROVING CHEMOTHERAPY/BIOTHERAPY ADMINISTRATION: A TEAM APPROACH.

178
CASE REPORT: THE ZEVALIN TREATMENT REGIME IS SAFE AND EFFECTIVE IN RENAL IMPAIRMENT.

179
A TARGET IS NOT A TARGET: TRENDS IN TREATMENT, ADMINSTRATION, PATIENT EDUCATION; MANAGEMENT OF SIDE EFFECTS.

180
STRATEGIES FOR PREVENTION OF CHEMOTHERAPY MEDICATION ERRORS.

181
EXTRAPLEURAL PNEUMONECTOMY FOR MESOTHELIOMA: SPECIALIZED NURSING CARE IS ESSENTIAL TO MINIMIZE POSTOPERATIVE COMPLICATIONS.

182
LATEST SURGICAL INTERVENTION FOR PROSTATE CANCER: LAPAROSCOPIC RADICAL PROSTATECTOMY.

183
NURSING CONSIDERATIONS FOR ROTATIONPLASTY IN TUMOR SURGERY.

184
FATIGUE, INSOMNIA, AND DEPRESSION: A SYMPTOM CLUSTER DURING BREAST CANCER THERAPY.

185
THE RELATIONSHIP OF SOCIAL SUPPORT, PERSONAL FACTORS, PSYCHOLOGICAL AND PHYSICAL STATES AMONG JAPANESE WOMEN WITH BREAST CANCER: A PREOPERATIVE PHASE.

186
SYMPTOM EXPERIENCE OF BREAST CANCER SURVIVORS.

187
SECONDARY ANALYSIS OF LYMPHEDEMA INCIDENCE, PREVENTION AND MANAGEMENT IN BREAST CANCER SURVIVORS.

188
UNDERSTANDING DELAY IN BREAST CANCER DIAGNOSIS IN DIVERSE YOUNG WOMEN.

189
HOW DO NURSE CASE MANAGERS CARE FOR OLDER WOMEN WITH BREAST CANCER?

190
ATTITUDINAL DIFFERENCES AMONG WOMEN WITH AND WITHOUT A FAMILY HISTORY OF BREAST CANCER.

191
HEALTH BELIEFS AND PRACTICES RELATED TO BREAST CANCER SCREENING IN FILIPINO, CHINESE, AND ASIAN INDIAN WOMEN.

192
WOMEN WHO SAY NO TO MAMMOGRAPHY.

193
DETERMINANTS OF SELF-EFFICACY IN EXERCISE AMONG BREAST CANCER SURVIVORS.

194
RELIABILITY AND VALIDITY OF THE M.D. ANDERSON SYMPTOM INVENTORY (MDASI-BT) IN THE PRIMARY BRAIN TUMOR PATIENT POPULATION.

195
VIRTUAL REALITY INTERVENTION FOR CHEMOTHERAPY SYMPTOMS.

196
A BRIEF SLEEP INTERVENTION FOR FAMILY CAREGIVERS.

197
SYMPTOM CLUSTERS IN CANCER PATIENTS: IDENTIFICATION AND VERIFICATION.

198
ADVANCING OUR KNOWLEDGE OF SYMPTOM CLUSTERS.

199
PROFILE OF CANCER RELATED SYMPTOMS PRIOR TO CHEMOTHERAPY.

200
HEMOGLOBIN (HB) RESPONSE AND IMPROVEMENTS IN QUALITY OF LIFE (QOL) IN ANEMIC CHILDREN WITH CANCER RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY (MCT).

201
SYMPTOMS, SELF-CARE AND QUALITY OF LIFE OF DISADVANTAGED CHINESE-SPEAKING CANCER PATIENTS: A PILOT STUDY.

202
PATIENTS UNDERGOING RADIATION TREATMENT WERE CLINICALLY EVALUATED FOR SKIN INTEGRITY, PAIN AND ITCHING IN A PRELIMINARY TRIAL USING RADIAPLEXRX GEL CONTAINING 0.2 HYALURONIC ACID.

203
SYSTEMATIC REVIEW OF THE EFFECTS OF MASSAGE ON CANCER PAIN IN ADULTS.

204
COMPLEMENTARY AND ALTERNATIVE MEDICINE: ONCOLOGY NURSES KNOWLEDGE, ATTITUDE, AND EXPERIENCE.

205
COMPLEMENTARY THERAPIES USED BY HISPANIC WOMEN WITH BREAST CANCER.

206
CANCER PAIN EXPERIENCE AS EXPRESSED BY PATIENTS THROUGH AN ONLINE FORUM.

207
INTERNET COMMUNITIES/GROUPS FOR ETHNIC MINORITIES.

208
DECISION SUPPORT COMPUTER PROGRAM FOR CANCER PAIN MANAGEMENT: APPROPRIATENESS, ACCURACY, AND ACCEPTABILITY.

209
RECRUITMENT OF ONCOLOGY NURSES THROUGH THE INTERNET.

210
ADVANCES IN CONDUCTING RETROSPECTIVE CHART REVIEW STUDIES: USE OF ELECTRONIC REPORT FORMS AND DATABASE IN A COMMUNITY STUDY IN ANEMIC PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS).

211
A STUDY OF SUN PROTECTION PRACTICES IN STATE LICENSED DAY CARE CENTERS.

212
BASELINE EVALUATION OF ASSESSMENT, INFORMATION, AND MANAGEMENT PATTERNS IN A NATIONAL QUALITY IMPROVEMENT PROJECT (AIM HIGHER).

213
LUNG CANCER PATIENTS PERCEPTIONS OF THEIR AWARENESS OF TREATMENT OPTIONS, SELF-ASSESSMENT OF KNOWLEDGE AND LEVEL OF SATISFACTION WITH PRETREATMENT EDUCATION.

214
YOU JUST HAVE TO BE STRONG.

215
CHARACTERISTICS OF LUNG CANCER SCREENING PARTICIPANTS.

216
SLEEP DISTURBANCE IN KOREAN GASTRIC CANCER PATIENTS AND THEIR FAMILY CAREGIVERS.

217
DEVELOPING AND IMPLEMENTING A PSYCHOSOCIAL CARE PROGRAM IN A COMMUNITY ONCOLOGY PRACTICE.

218
OUTCOMES FROM 5 YEARS OF CANCER PREVENTION AND SCREENING EDUCATION.

219
CLINICAL TRIALS AND THE ELDERLY: AN EVIDENCED-BASED PROTOCOL.

220
METHODS AND OUTCOMES FOR RECRUITMENT OF CASES AND CONTROLS FOR A BRAIN TUMOR EPIDEMIOLOGY STUDY.

221
TAKING IT TO THE STREETS: OPENING CLINICAL TRIALS SITES IN THE COMMUNITY.

222
CLINICAL TRIAL RECRUITMENT: THE IMPACT OF THE ONCOLOGY NURSE.

223
ASK ME ABOUT CLINICAL TRIALS: A PROMOTION TO INCREASE STAFF, PATIENT AND COMMUNITY AWARENESS ABOUT CLINICAL TRIALS IN A COMPREHENSIVE CANCER CENTER.

224
CLINICAL RESEARCH NURSING CHALLENGE: CALMING NURSES FEARS WHEN USING SMALLPOX VACCINE AS CUTTING EDGE CANCER THERAPY.

225
NAVIGATING THE POTHOLES ALONG THE RESEARCH HIGHWAY: IMPLEMENTING A RESEARCH STUDY.

226
INITIATING NURSING RESEARCH AT YOUR INSTITUTION: INQUIRING MINDS WANT TO KNOW.

227
THE IMPACT OF SCREENING PATIENTS FOR CLINICAL TRIALS: RESOURCES AND COSTS.

228
CLINICAL STUDY PATIENT CARE COORDINATION—IT IS POSSIBLE!

229
TECHNIQUES TO DECREASE ATTRITION IN CLINICAL STUDIES.

230
THE ROLE OF THE NURSE PRACTITIONER IN CERVICAL CANCER DETECTION—SERVING THE UNDERSERVED.

231
ABSTRACT WITHDRAWN.

232
HOW THE ROLE OF A WOCN IN AN AMBULATORY CANCER CARE CENTER IMPACTS A PATIENTS QUALITY OF LIFE.

233
CRITERIA FOR THE ONCOLOGY NURSE PRACTITIONER TO WRITE ONGOING ANTINEOPLASTIC ORDERS.

234
ONCOLOGY APNS: IDENTIFYING AND BRIDGING THE GAP BETWEEN MEDICINE AND NURSING IN INPATIENT ONCOLOGY CARE.

235
IMPROVING CARE DELIVERY: THE ROLE OF THE ADVANCED PRACTICE NURSE IN PERFORMANCE IMPROVEMENT.

236
CNS AND NP COLLABORATION FOR DEPRESSION MANAGEMENT.

237
NEW PRODUCT INTRODUCTION: THE PHARMACEUTICAL CLINICAL EDUCATOR’S ROLE.

238
NURSING IMPLICATIONS IN MANAGING GRAFT VERSUS HOST DISEASE IN NONMYELOABLATIVE HLA-HAPLOIDENTICAL TRANSPLANTS IN THE OUTPATIENT SETTING.

239
THE ROLE OF PHOTOPHERESIS IN MANAGING CHRONIC CUTANEOUS GRAFT-VERSUS-HOST-DISEASE IN ADULTS AND CHILDREN.

240
ANALYSIS OF THE INPATIENT NURSING MANAGEMENT OF PATIENTS UNDERGOING NONMYELOABLATIVE CONDITIONING AND PARTIALLY HLA-MISMATCHED BONE MARROW TRANSPLANTATION.

241
EFFECTIVE MANAGEMENT OF CHRONIC GRAFT VERSUS HOST DISEASE (GVHD) IN THE ALLOGENEIC BMT PATIENT.

242
MENOPAUSAL CONCERNS OF BREAST CANCER SURVIVORS: CLINICAL EXPERIENCE AND REVIEW OF THE LITERATURE.

243
PREFERENCES FOR ORAL VERSUS PARENTERAL ANTITUMOR THERAPY: A SURVEY OF PATIENTS WITH METASTATIC BREAST CANCER.

244
UNCERTAINTY: PATIENT DECISION MAKING IN BREAST CANCER.

245
PROSTATE CANCER STAGING: ENDORECTAL MAGNETIC RESONANCE IMAGING.

246
IDENTIFYING COMPLEMENTARY & ALTERNATIVE MEDICINE (CAM) USE IN MEN: AN EVIDENCE BASED MODEL FOR PATIENT EDUCATION.

247
THE NEW PRE-OPERATIVE SEDATION: IMPLEMENTATION OF AN INNOVATIVE MUSIC PROGRAM IN THE PRE-SURGICAL CENTER AT A MAJOR CANCER CENTER.

248
CREATION OF A NEW ONCOLOGY NURSING CARE DELIVERY SYSTEM.

249
BRIDGING THE GAP: DESIGNING AN ONCOLOGY NURSING CONSULT SERVICE.

250
CHEMOTHERAPY PATIENT CALL BACK QI PROJECT.

251
AN EVALUATION OF NURSING ACTIVITIES DURING CHEMOTHERAPY INFUSION OF VARIOUS DURATIONS.

252
THE BREAST CANCER JOURNEY: AN EVALUATION PROJECT.

253
COLLABORATIVE PRACTICE: MULTIPLE MODELS PRODUCE SIMILAR OUTCOMES.

254
ACTUALIZING A WELLNESS PROGRAM AND WELLNESS ROOM IN THE ONCOLOGY SETTING: GETTING A PROGRAM THROUGH A LARGE INSTITUTION.

255
BUILDING BLOCKS FOR A STRONG PATIENT CARE ENVIRONMENT.

256
IMPROVING SATISFACTION OF IL-2 PATIENTS: LOCATION, LOCATION, LOCATION.

257
A DATABASE APPROACH TO GRIEF AND LOSS PROGRAM MANAGEMENT.

258
A MULTIDISCIPLINARY APPROACH TO IMPROVING BED AVAILABILITY FOR ONCOLOGY PATIENTS.

259
DEVELOPMENT OF A NURSE-SENSITIVE DASHBOARD TO IMPLEMENT THE STAFFING EFFECTIVENESS STANDARD IN AN OUTPATIENT ONCOLOGY SETTING.

260
INTEGRATING VOLUNTEERS INTO THE ONCOLOGY TEAM: ROLES, RESPONSIBILITIES AND REWARDS.

261
AMBULATORY ONCOLOGY NURSES: FACING EXTINCTION OR HERE TO STAY?

262
NEEDS ASSESSMENT FOR DEVELOPMENT OF AN ONCOLOGY VOLUNTEER PROGRAM.

263
ONCOLOGY NURSING CLINICAL INTERNSHIP IMPROVES RECRUITMENT AND RETENTION.

264
BUILDING RELATIONSHIPS WITH UNIVERSITIES TO PROMOTE ONCOLOGY NURSING.

265
THE NURSING SHORTAGE: A COMPREHENSIVE CANCER CENTERS STRATEGY TO ATTRACT AND RETAIN ONCOLOGY NURSES.

266
ONCOLOGY NURSE ACADEMY: A FRESH APPROACH TO RECRUITMENT AND RETENTION.

267
BREAKING THE LANGUAGE BARRIER: THE NURSES ROLE IN TREATING NON-ENGLISH SPEAKING PATIENTS IN ONCOLOGY CLINICAL TRIALS.

268
OPTIMIZING CHEMOTHERAPY-INDUCED ANEMIA (CIA) MANAGEMENT WITH THE USE OF PATIENT FLOW SHEETS.

269
DEVELOPMENT OF EVIDENCE-BASED BLEEDING PRECAUTIONS.

270
IRON, FOLATE AND CANCER-RELATED ANEMIA: PERFECT TOGETHER.

271
RAPID RESPONSE—STANDING ORDERS FOR NEUTROPENIC FEVER.

272
ADMISSION AND CARE OF THE FEBRILE NEUTROPENIC PATIENT IN A COMMUNITY HOSPITAL SETTING.

273
PREDICTORS FOR CHEMOTHERAPY-INDUCED NEUTROPENIA AND ITS COMPLICATIONS BASED ON A PROSPECTIVE NATIONWIDE REGISTRY.

274
A MULTIDISCIPLINARY APPROACH TO ESTABLISHING ANEMIA GUIDELINES.

275
UTILIZING QUALITY OF LIFE (QOL) AS A FACTOR IN TREATMENT CHOICES FOR CHEMOTHERAPY INDUCED ANEMIA (CIA).

276
NEUTROPENIC DIET IN THE IMMUNOSUPPRESSED PATIENT: PROS AND CONS AND VARIATIONS IN THEIR TREATMENT PLAN.